The diagnosis of acquired sensory neuropathies;Diagnostic des neuropathies sensitives acquises

Revue Neurologique

Volumn 160, Issue 3, 2004, Pages 363-370

  Creange A ^a,b,c  

^a FACULTÉ DE MÉDECINE   (France)

^b INSERM   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

Polyradiculoneuritis; Sensory neuronopathy; Sensory polyneuropathy

Indexed keywords

IMMUNOGLOBULIN M;

CLINICAL EXAMINATION; CLINICAL FEATURE; DEMYELINATING NEUROPATHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROPHYSIOLOGY; FRANCE; GLUCOSE INTOLERANCE; HUMAN; LEPROSY; MEDICAL LITERATURE; MONOCLONAL IMMUNOGLOBULINEMIA; NERVE CONDUCTION; NEURITIS; NEUROPATHOLOGY; PARANEOPLASTIC SYNDROME; POLYNEUROPATHY; REVIEW; SENSORIMOTOR NEUROPATHY; SENSORY NEUROPATHY; SJOEGREN SYNDROME; VASCULITIS;

EID: 1642286510     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(04)70917-0     Document Type: Short Survey

References (61)

1. ASBURY AK. (1981). Diagnostic considerations in Guillain-Barré syndrome. Ann Neurol, 9(suppl): 1-5.
2. ASBURY AK, PICARD EH, BARINGER JR. (1972). Sensory perineuritis. Arch Neurol, 26: 302-312.
3. AUGER RG, WINDEBANK AJ, LUCCHINETTI CF, CHALK CH. (1999). Role of the blink reflex in the evaluation of sensory neuronopathy. Neurology, 53: 407-408.
4. AUTHIER FJ, LECHAPT E, CRÉANGE A, VOISIN MC, GHERARDI RK. (1999). Labial salivary gland biopsy in etiologic investigation of neuropathies. Muscle Nerve, 22: 105-107.
5. BERGER AR, HERSKOVITZ S, KAPLAN J. (1995). Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy". Muscle Nerve, 18: 440-444.
6. CAMDESSANCHÉ JP, ANTOINE JC, HONNORAT J et al. (2002). Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies. A clinical and electrophysiological study of 20 patients. Brain, 125: 166-175.
7. CHIA L, FERNANDEZ A, LACROIX C, ADAMS D, PLANTÉ V, SAID G. (1996). Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain, 119: 1091-1098.
8. CHINN JS, SCHUFFLER MD. (1988). Paraneoplastic visceral neuropathy as a cause of severe gastrointestinal motor dysfunction. Gastroenterology, 95: 1279-1286.
9. CROS D, CHIAPPA KH, PATEL S, GOMINAK S. (1992). Acquired pure sensory demyelinating polyneuropathy: a chronic inflammatory demyelinating polyradiculoneuropathy variant? Ann Neurol, 32: 280.
10. DALAKAS MC. (1986). Chronic idiopathic ataxic neuropathy. Ann Neurol, 19: 545-554.
11. DENNY-BROWN D. (1948). Primary sensory neuropathy with muscular changes by carcinoma. J Neurol, 11: 73-87.
12. DURAND MC, GOULON-GOEAU C, SCHWEITZER A, CHELIOUT-HERAUT F, RAPHAEL JC, GAJDOS P. (2001). Electrophysiologic study of 10 cases of Miller Fisher syndrome. Rev Neurol (Paris), 157: 72-79.
13. DYCK P, GRANT I, FEALEY R. (1996). Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology, 47: 10-17.
14. GABRIEL CM, HOWARD R, KINSELLA N et al. (2000). Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry, 69: 442-446.
15. GAIST D, JEPPESEN U, ANDERSEN M, GARCIA RODRIGUEZ LA, HALLAS J, SINDRUP SH. (2002). Statins and risk of polyneuropathy: a case-control study. Neurology, 58: 1333-1337.
16. GRANT IA, HUNDER GG, HOMBURGER HA, DYCK PJ. (1997). Peripheral neuropathy associated with sicca complex. Neurology, 48: 855-862.
17. GRAUS F, KEIME-GUIBERT F, REÑE R et al. (2001). Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain, 124: 1138-1148.
18. GRIFFIN JW, CORNBLATH DR, ALEXANDER E et al. (1990). Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol, 27: 304-315.
19. HARRIS MI, FLEGAL KM, COWIE CC et al. (1998). Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diab Care, 21: 518-524.
20. HOLLAND NR, CRAWFORD TO, HAUER P, CORNBLATH DR, GRIFFIN JW, MCARTHUR JC. (1998). Small-fiber sensory neuropathies: clinical course and neuropathology of idiopathic cases. Ann Neurol, 44: 47-59.
21. HUGHES RAC. (2002). Peripheral neuropathy. Br Med J, 324: 466-469.
22. JACOBS BC, O'HANLON GM, BREEDLAND EG, VEITCH J, VAN DOORN PA, WILLISON HJ. (1997). Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides. J Neuroimmunol, 80: 23-30.
23. JANN S, BERETTA S, BRAMERIO M, DEFANTI CA. (2001). Prospective follow-Up study of chronic polyneuropathy of undetermined cause. Muscle Nerve, 24: 1197-1201.
24. KAKU DA, ENGLAND JD, SUMNER AJ. (1994). Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulfated glucuronyl paragloboside. Brain, 17: 941-947.
25. KATZ JS, SAPERSTEIN DS, GRONSETH G, AMATO AA, BAROHN RJ. (2000). Distal acquired demyelinating symmetric (DADS) neuropathy. Neurology, 54: 615-620.
26. KONANC DA, O'NEILL BP, CASELLI RJ, LENNON VA. (1995). Peripheral neuropathic presentation in 3 patients with seropositivity for type 1 anti-Purkinje cell antibodies (PCA-1) and ovarian or related Mullerian carcinoma. Neurology, 45(Suppl 2): A320.
27. LAURIA G, SGHIRLANZONI A, LOMBARDI R, PAREYSON D. (2001). Epidermal nerve fiber density in sensory ganglionopathies: clinical and neurophysiologic correlations. Muscle Nerve, 24: 1034-1039.
28. LEFAUCHEUR JP, BRUA A, CRÉANGE A, DROUOT X, JARRY G. (2002). Clinical application of laser evoked potentials using the Nd:YAG laser. Neurophysiol Clin, 32: 91-98.
29. LEFAUCHEUR JP, DEBRAY S, JARRY G. (2001). Laser evoked potentials using the Nd:YAG laser. Muscle Nerve, 24: 496-501.
30. LEWIS RA, SUMNER AJ, BROWN MJ, ASBURY AK. (1982). Multifocal demyelinating neuropathy with persistent conduction block. Neurology, 32: 958-964.
31. MAISONOBE T, LE-FORESTIER N, BOUCHE P. (1996). Electrophysiologic study, diagnosis and cases of acquired sensory polyneuropathy. Neurophysiol Clin, 26: 202-215.
32. MATTHEWS WB, SQUIER MV. (1988). Sensory perineuritis. J Neurol Neurosurg Psychiatry, 51: 473-475.
33. MOLINUEVO JL, GRAUS F, SERRANO C, RENE R, GUERRERO A, ILLA I. (1998). Utility of anti-Hu antibodies in the diagnosis of paraneoplastic sensory neuropathy. Ann Neurol, 44: 976-980.
34. MYGLAND A, MONSTAD P. (2001). Chronic polyneuropathies in Vest-Agder, Norway. Eur J Neurol, 8: 157-165.
35. NICOLAS G, MAISONOBE T, LE FORESTIER N, LEGER JM, BOUCHE P. (2002). Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve, 25: 26-30.
36. NICOLLE MW, BARRON JR, WATSON BV, HAMMOND RR, MILLER TA. (2001). Wartenberg's migrant sensory neuritis. Muscle Nerve, 24: 438-443.
37. NOTERMANS NC, WOKKE JHJ, FRANSSEN H et al. (1996). Chronic idiopathic axonal polyneuropathy. Comparison of patients with and without monoclonal gammopathy. Brain, 119: 421-427.
38. NOTERMANS NC, WOKKE JHJ, FRANSSEN H et al. (1993). Chronic idiopathic axonal polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry, 56: 1066-1071.
39. NOTERMANS NC, WOKKE JHJ, VAN DER GRAAF Y, FRANSSEN H, VAN DIJK GW, JENNEKENS FGI. (1994). Chronic idiopathic axonal polyneuropathy: a five year follow up. J Neurol Neurosurg Psychiatry, 57: 1525-1527.
40. NOVELLA SP, INZUCCHI SE, GOLDSTEIN JM. (2001). The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve, 24: 1229-1231.
41. OH SJ, GURTEKIN Y, DROPCHO E, KING P, CLASSEN GC. (2001a). Diverse electrophysiological spectrum of anti-Hu antibody positive neuropathy [abstract]. Neurology, 56(Suppl 3): S61.001.
42. OH SJ, JOY JL, KURUOGLU R. (1992). "Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry, 55: J677-680.
43. OH SJ, LAGANKE C, CLAUSSEN GC. (2001b). Sensory Guillain-Barré syndrome. Neurology, 56: 82-86.
44. PESTRONK A, CHOKSI R, BIESER K et al. (1994). Treatable gait disorder and polyneuropathy associated with high titer serum IgM binding to antigens that copurify with myelin-associated glycoprotein. Muscle Nerve, 17: 1293-1300.
45. POLYDEFKIS M, YIANNOUTSOS CT, COHEN BA et al. (2002). Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology, 58: 115-119.
46. POUGET J, VERSCHUEREN A, AZULAY JP, ATTARIAN S. (2001). Le syndrome de Lewis et Sumner. Rev Neurol (Paris), 157: 1561-1564.
47. REES JH, HAIN SF, JOHNSON MR et al. (2001). The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders. Brain, 124: 2223-2231.
48. ROSENBERG NR, PORTEGIES P, DE VISSER M, VERMEULEN M. (2001). Diagnostic investigation of patients with chronic polyneuropathy: evaluation of a clinical guideline. J Neurol Neurosurg Psychiatry, 71: 205-209.
49. SIMMONS Z, TIVAKARAN S. (1996). Acquired demyelinating polyneuropathy presenting as a pure clinical sensory syndrome. Muscle Nerve, 19: 1174-1176.
50. SINGLETON JR, SMITH AG, BROMBERG MB. (2001). Painful sensory polyneuropathy associated with impaired glucose tolerance. Muscle Nerve, 24: 1225-1228.
51. SUAREZ GA, CHALK CH, RUSSELL JW, KIM SM, O'BRIEN PC, DYCK PJ. (2001). Diagnostic accuracy and certainty from sequential evaluations in peripheral neuropathy. Neurology, 57: 1118-1120.
52. SUMNER CJ, SHETH S, GRIFFIN JW, CORNBLATH DR, POLYDEFKIS M. (2003). The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology, 60: 108-111.
53. SUSUKI K, KOGA M, YUKI N, JOHKURA K, KUROIWA Y. (1999). Chronic sensory ataxic neuropathy associated with IgM antibody against b-series gangliosides including GD1b. Rinsho Shinkeigaku, 39: 967-970.
54. SUSUKI K, YUKI N, HIRATA K. (2001). Features of sensory ataxic neuropathy associated with anti-GD1b IgM antibody. J Neuroimmunol, 112: 181-187.
55. TAKEUCHI H, MISU K, HATTORI N, NAGAMATSU M, SOBUE G. (2000). Immunoglobulin therapy for idiopathic chronic sensory ataxic neuropathy. Neurology, 54: 1008-a-1010.
56. THOMAS PK, OCHOA J. (1993). Clinical features and differencial diagnosis. In: Dyck PJ, Thoma PK, Lambert EH et Bunge R (eds.). Peripheral Neuropathy. Vol. 1, Saunders. Philadelphia: pp. 756-764.
57. WARTENBERG R. (1958). Sensory polyneuritis. In: Wartenberg R (eds.). Neuritis, sensory neuritis, neuralgia., Oxford University Press. New York: pp. 160-162.
58. WINDEBANK AJ, BLEXRUD MD, DYCK PJ, DAUBE JR, KARNES JL. (1990). The syndrome of acute sensory neurapathy: Clinical features and electrophysiologic and pathologic changes. Neurology, 40: 584-591.
59. WOKKE JHJ, VAN DUK GW. (1997). Sensory neuropathies including painful and toxic neuropathies. J Neurol, 244: 209-221.
60. YASUDA T, SOBUE G, MOKUNO K et al. (1995). Clinico-pathophysiologic features of actue autonomic and sensory neuropathy: a long term follow-up study. J Neurol, 242: 623-628.
61. YUKI N, MIYANTANI N, SATO S et al. (1992). Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNacβ1-4(Gal3-2αNeuAc8-2αNeuAc)β1. Neurology, 42: 686-689.